Research > ETFs > ETF / ETP Commentary > 

Why Emerging Markets Equities Continue to Pull in Huge Inflows

Emerging markets equities investing continues to be a top theme. Following a standout year in 2025, investors have flooded ex-U.S. equities with dollars, setting records for inflows in January. Emerging markets continue to pick up a sizable chunk of those flows, with emerging markets equities ETF AVEM adding $1 billion in flows in just the last week. See more: Could Quality Stocks Be the Key to Unlocking the 2026 Equities Outlook? Why, then, are these equities picking up such significant flows? Multi-year and near-term tailwinds are boosting the category’s appeal. For one, many investors appear to be pushing their assets into tech firms offering a degree of diversification away from the big U.S. names.  SK Hynix (000660), a key South Korean tech firm, has returned some 50.4% YTD, for example. The chip manufacturer benefits from the ravenous global demand for its products, of course, but also can help diversify portfolios heavily invested in AI hyperscalers. Of course, strong emerging markets equities performance has not been limited to the tech-dominated East Asian markets. Commodities helped lift many African equities to a strong performance last year, while trends continue to be positive in South American markets like Brazil and Peru. Emerging Markets Equities ETFs: Records to BreakA declining dollar may be helping to drive investor dollars abroad. Lower valuations in foreign markets, too, could appeal when compared to expensive U.S. stocks. Whether those dollars are chasing last year’s performance too much or not, opportunities continue for the category to play a strong satellite role.  That’s where ETFs like AVEM can appeal. The Emerging Markets Equity ETF (AVEM ), charges a 33 basis point (bps) fee. The fund actively invests in emerging markets stocks of all capitalization. Where passive equities ETFs simply look to the largest market cap names, AVEM offers a deeper, more flexible focus. Together, that has helped the fund return 49.7% over the last twelve months per ETF Database data. What’s more, it has added a robust $1 billion in net inflows in just the last week. Overall, its AUM has now exceeded $20 billion in total – the second ETF from Avantis Investors to reach that marker. For those wanting emerging markets equities options as flows continue, AVEM can appeal. For more news, information, and analysis, visit the Core Strategies Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.